ArticleFoods (Basel, Switzerland)2026
Arsenic in Chinese Crayfish: Speciation Analysis, Cooking-Induced Stability, Bioaccessibility, and Dietary Risk Assessment.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Arsenic (As) contamination in aquatic products is a significant public health concern. This study presents a holistic investigation into the speciation, processing stability, bioaccessibility, and health risks of arsenic in crayfish from the Yangtze River basin. The analysis of 60 samples revealed total arsenic (tAs) concentrations ranging from 53.6 to 419.9 μg/kg, with a mean of 109.3 μg/kg. Arsenic occurred predominantly as low-toxicity organic species, with arsenobetaine accounting for 41.3% of tAs on average, while inorganic arsenic (iAs) constituted only 11.6% (mean 12.5 μg/kg). Evaluation of common cooking methods demonstrated that arsenic speciation remained largely stable, with no increase in toxic iAs forms. Notably, boiling in saline water led to significant leaching, reducing iAs content by 28.2%. In vitro gastrointestinal digestion revealed a markedly high bioaccessibility of iAs (81.0-99.3% in the intestinal phase), far exceeding that of tAs (50.4-74.6%). Health risk assessment based on the latest U.S. EPA parameters indicated negligible non-carcinogenic risk across all exposure scenarios. However, the estimated carcinogenic risk for high-intake consumers of high-iAs samples exceeded the acceptable threshold of concern. These findings are expected to provide essential data for understanding the health risks posed by arsenic in crayfish and to support accurate food safety evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.